This product is non invasive and does not expose the body to open wounds that can get infected and lead to complications. Next generation device to address a deadly illness. More hospitals will have interest in this devise.
Sentiment: Strong Buy
Should be able to at least catch up with market,, 30 by december should be a strong possibility
Think it was .51 closing price not .505
Technical sweet spot for big market roll
I don't think the potential is being realized correctly right now. Other small cos with this area of asset under development are high single digit to double digits in market price . This is the hottest area of drug development in biotech. One of your messengers was alluding to this area being exciting. If co takes the correct disclosure of potential in the upcoming period, we will see a confirm of a secular movement for this stock that was not able to be achieved in the last five years or more. Cheap from any view you take.
So far indicating .45 technical support area.. Will see on follow through at close. This may be in for an excellent run. Time will confirm or indicate exit. Right now stock strong and very positive sustained and reasonable upside movement.
Should move into the .50's with the momentum movement in place. Then expect some back and fill if we get to .75. The patent once given some industry review should be a big mover once confirmed by respected source
Volume strong.. momentum still in tack.. Will have to see if holds upward pattern. closed above break out price.
even at last hint of product strentgth range of 1.25 -1.87 was normalized pricing of stock.
Not even being priced at hese levels although product strength probably triple past history.
Don't need a Kramer yes to hit new high. Might happen latter this month on bio news or aggressive acquisition
Pipeline strong and will generate strong cash flows Don't know why Kramer making a cloud over stock..
very important chart pattern right now...news was very positive and could be beginning of achievement period with products for cancer and maybe other areas as well. would like more frequent news updates from the company on products and potentials with some guidance of how close to potential final trials and spprovals.